Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 340

BillFederalSenateFloor Consideration
A bill to promote competition in the market for drugs and biological products by facilitating the timely entry of lower-cost generic and biosimilar versions of those drugs and biological products.
About This Bill
Floor Vote
Latest Action · February 6, 2019
Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 22.
Introduced
February 5, 2019
Cosponsors (41)
22D 18R
View PDF ↗
SummaryFull TextCommentsAnnotations

Public Comments (0)

No comments yet. Be the first to weigh in from the Take Action box.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.